ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >SR9009

SR9009

SR9009 Structure
CAS No.
1379686-30-2
Chemical Name:
SR9009
Synonyms
STENABOLIC;REV-ERB Agonist II;SR9009;CS-2027;Buy SR9009;SR9009 Sarms;SR9009 Powder;SR9009 USP/EP/BP;SR9009,Stenabolic,;Stenabolic (SR9009)
CBNumber:
CB42672926
Molecular Formula:
C20H24ClN3O4S
Molecular Weight:
437.94
MOL File:
1379686-30-2.mol
Modify Date:
2024/5/29 17:03:55

SR9009 Properties

Melting point 79-81°C
Boiling point 547.2±45.0 °C(Predicted)
Density 1.327±0.06 g/cm3(Predicted)
storage temp. -20°
solubility Soluble in DMSO (greater than 25 mg/ml) or in Ethanol (up to 20 mg/ml).
form solid
pka 6.12±0.50(Predicted)
color Tan
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.
InChI InChI=1S/C20H24ClN3O4S/c1-2-28-20(25)23-10-9-16(13-23)12-22(11-15-3-5-17(21)6-4-15)14-18-7-8-19(29-18)24(26)27/h3-8,16H,2,9-14H2,1H3
InChIKey MMJJNHOIVCGAAP-UHFFFAOYSA-N
SMILES N1(C(OCC)=O)CCC(CN(CC2=CC=C(Cl)C=C2)CC2SC([N+]([O-])=O)=CC=2)C1

SR9009 price More Price(1)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) 554726 REV-ERB Agonist II, SR9009 - Calbiochem The REV-ERB Agonist II, SR9009 controls the biological activity of REV-ERB. This small molecule/inhibitor is primarily used for Biochemicals applicati 1379686-30-2 25MG ₹15910 2022-06-14 Buy
Product number Packaging Price Buy
554726 25MG ₹15910 Buy

SR9009 Chemical Properties,Uses,Production

Description

SR-9009 is an agonist at nuclear receptor Rev-ErbA. Greatly diminishes VILI-induced lung edema, inflammatory cell infiltration and TNFα production in a rat lung injury model. SR-9009 suppresses atherosclerosis in a mouse model. Specifically lethal to cancer cells and oncogene-induced senescent cells with no effect on the viability of normal cells or tissues. Disrupts pain associated with osteoarthritis by reducing BMAL1 expression in bmal1f/fNav1.8CreERT mice.

Uses

SR 9009 is a synthetic REV-ERB agonist that regulates circadian behavior and metabolism; has potential use in the treatment of sleep disorders and metabolic diseases. It is a lead compound for a new class of cancer drugs associated with the body’s circadian clock.

Pharmaceutical Applications

SR9009 is a research drug that was developed by professor Thomas Burris of the Scripps Research Institute as an agonist of Rev-ErbA (i.e., increases the constitutive repression of genes regulated by Rev-ErbA) with a half-maximum inhibitory concentration (IC50) = 670 nM for Rev-ErbAα and IC50 = 800 nM for Rev-ErbAβ.

Biological Activity

REV-ERBα and REV-ERBβ nuclear receptors are transcriptional repressors that coordinate circadian rhythm and metabolic pathways in a heme-dependent manner. SR9009 is a REV-ERB agonist that increases the constitutive repression of genes regulated by REV-ERBα and REV-ERBβ with IC50 values of 670 and 800 nM, respectively. Through activation of REV-ERB, SR9009 has been shown to decrease circadian locomotor activity during the dark phase and to alter the expression pattern of core clock genes in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes in the liver, skeletal muscle and adipose tissue was also shown to be altered in mice exposed to SR9009, resulting in increased energy expenditure. Diet-induced obese mice treated with 100 mg/kg SR9009 (i.p. two times a day for 30 days) have been reported to display decreased fat mass and markedly improved dyslipidemia and hyperglycemia.

Side effects

So far, no side effect caused by SR9009 has been identified. It can then be rightly said that the supplement is very safe to consume. SR9009 does not influence the hormones in any way and so won’t aromatize into the estrogen, and won't suppress the production of testosterone. Just like other supplements like SARMS, SR9009 does not deposit toxins in the liver, though it is needful for there to be some supplements that will support the liver when using it. 3 to 5 capsules of N2Guard taken every day will serve as good support to the kidney and liver.

References

1) Solt et al. (2012) Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists; Nature, 485 62
2) Li et al. (2014) A study on circadian rhythm disorder of rat lung tissue caused by mechanical ventilation induced lung injury; Int.Immunopharmacol. 18 249
3) Sitaula et al. (2015) Suppression of atherosclerosis by synthetic REV-ERB agonist; Biochem. Biophys. Res. Commun.,460 566
4) Sulli et al. (2018) Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence; Nature, 553 351
5) Das et al. (2018) Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain; Gene 655 1
6) Solt LA,Wang Y,Banerjee S,Hughes T,Kojetin DJ,Lundasen T,Shin Y,Liu J,Cameron MD,Noel R,Yoo SH,Takahashi JS,Butler AA,Kamenecka TM,Burris TP. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature.2012 Mar 29;485(7396):62-8.

Global( 189)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Powerhouse Nutritions Private Limited 08048951600 Haryana, India 10 58 Inquiry
City Cat Overseas Chemicals Limited 09121144735 Mumbai, India 9 58 Inquiry
Healthster Co. 08048361308Ext 798 Delhi, India 1 58 Inquiry
Kapil Enterprises 08047301824 Delhi, India 6 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Changzhou Xuanming Pharmaceutical Technology Co., Ltd. +8618068519287 China 833 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
Wuhan Cell Pharmaceutical Co., Ltd +86-13129979210 +86-13129979210 China 376 58 Inquiry
hebei hongtan Biotechnology Co., Ltd +86-86-1913198-3935 +8617331935328 China 973 58 Inquiry
Hebei Mojin Biotechnology Co., Ltd +86 13288715578 +8613288715578 China 12460 58 Inquiry

Related articles

  • What is SR9009?
  • SR9009 is a REV-ERB agonist that increases the constitutive repression of genes regulated by REV-ERBα and REV-ERBβ with IC50 v....
  • Mar 18,2022

Related Qustion

  • Q:Is SR9009 good for the liver?
  • A:SR9009 is effective in suppressing clinical markers of liver damage, circulating lipids, hepatic fibrosis, and markers of inf....
  • Apr 9,2024
SR9009 3-[[[(4-Chlorophenyl)methyl][(5-nitro-2-thienyl)methyl]amino]methyl]-1-pyrrolidinecarboxylic acid ethyl ester ethyl-3-(((4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate SR9009 sarms,whnohe_lucy(at)163.com Ethyl 3-[[[(4-chlorophenyl)methyl][(5-nitro-2-thienyl)methyl]amino]methyl]-1-pyrrolidinecarboxylate CS-2027 SR9009 Powder whnohe_carolineat163.com Stenabolic (SR9009) SR9009,Stenabolic, Ethyl-3-({(4-chlorbenzyl)[(5-nitro-2-thienyl)methyl]amino}methyl)-1-pyrrolidincarboxyla SR9009 SARMs Raws Prohormone SR-9009 CAS 1379686-30-2 for Bodybuilding 1-pyrrolidinecarboxylic acid, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-, ethyl ester StenabolicSR9009 SARMs SR9009 USP/EP/BP 99% Purity SR9009 Powder Pharmaceutical Grade SR9009 SR9009 Sarms SR9009 Powder Buy SR9009 ethyl 3-({[(4-chlorophenyl)methyl][(5-nitrothiophen-2-yl)methyl]amino}methyl)pyrrolidine-1-carboxylate SR-9009 (Stenabolic)-1 gram(49) REV-ERB Agonist II STENABOLIC SR9009 sarms powder 1379686-30-2 1379686-47-0 1379683-30-2 SARMs(Selective androgen receptor modulator) 1379686-30-2 SARMS